This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Zacks Industry Outlook Highlights Omnicom Group, National CineMedia and Harte Hanks
by Zacks Equity Research
Omnicom Group, National CineMedia and Harte Hanks are part of the Zacks Industry Outlook article.
3 Advertising & Marketing Stocks to Watch Amid Industry Woes
by Zacks Equity Research
The Zacks Advertising and Marketing industry is expected to gradually reach the pre-pandemic healthy levels with an increase in service activities. OMC, NCMI and HHS are likely to ride on the digital marketing surge and client-centric strategies.
Interpublic Group (IPG) Lags Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Interpublic (IPG) delivered earnings and revenue surprises of -6.67% and 3.26%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Stagwell (STGW) Q2 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Stagwell (STGW) delivered earnings and revenue surprises of -20% and 4.04%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Information Services Group (III) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
ISG (III) delivered earnings and revenue surprises of 10% and 0.61%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Interpublic Group (IPG) Beats Q2 Earnings Estimates
by Zacks Equity Research
Interpublic (IPG) delivered earnings and revenue surprises of 23.33% and 2.91%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for May 5th
by Zacks Equity Research
LPX, HHS and UBS have been added to the Zacks Rank #5 (Strong Sell) List on May 5, 2023.
Omnicom (OMC) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Omnicom (OMC) delivered earnings and revenue surprises of 13.04% and 2.28%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Harte-Hanks (HHS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Harte-Hanks (HHS) closed at $9.41, marking a +0.11% move from the previous day.
Harte-Hanks (HHS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Harte-Hanks (HHS) closed the most recent trading day at $9.51, moving +0.11% from the previous trading session.
Harte-Hanks (HHS) Stock Moves -0.19%: What You Should Know
by Zacks Equity Research
Harte-Hanks (HHS) closed the most recent trading day at $10.60, moving -0.19% from the previous trading session.
Harte-Hanks (HHS) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Harte-Hanks (HHS) closed the most recent trading day at $10.68, moving -1.2% from the previous trading session.
Harte-Hanks (HHS) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Harte-Hanks (HHS) closed at $11.37 in the latest trading session, marking a +0.18% move from the prior day.
Harte-Hanks (HHS) Stock Moves -0.18%: What You Should Know
by Zacks Equity Research
Harte-Hanks (HHS) closed at $11.10 in the latest trading session, marking a -0.18% move from the prior day.
Harte-Hanks (HHS) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Harte-Hanks (HHS) closed at $12.10, marking a +0.75% move from the previous day.
Is Harte Hanks (HHS) Stock Outpacing Its Business Services Peers This Year?
by Zacks Equity Research
Here is how Harte-Hanks (HHS) and Core & Main (CNM) have performed compared to their sector so far this year.
Are Investors Undervaluing Harte Hanks (HHS) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include Herc Holdings, StoneX Group, Veritiv and Harte Hanks
by Zacks Equity Research
Herc Holdings, StoneX Group, Veritiv and Harte Hanks are part of the Zacks Screen of the Week article.
Look Beyond Profit, Bet on 4 Stocks With Increasing Cash Flows
by Moumita C. Chattopadhyay
Cash holds the key to the company's existence, development and success, and can be referred to as its lifeblood. So, companies with rising cash flows like HRI, SNEX, VRTV and HHS are worth buying.
Zacks.com featured highlights include StoneX Group, Harte Hanks, Veritiv and AMN Healthcare Services
by Zacks Equity Research
StoneX Group, Harte Hanks, Veritiv and AMN Healthcare Services are part of the Zacks Screen of the Week article.
4 Solid Net Profit Margin Stocks to Maximize Portfolio Returns
by Anirudha Bhagat
Here are four top-ranked stocks, SNEX, HHS, VRTV and AMN, with solid net profit margins that can contribute toward making a solid portfolio.
Harte-Hanks (HHS) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Harte-Hanks (HHS) closed at $13.55 in the latest trading session, marking a +1.5% move from the prior day.
Best Growth Stocks to Buy for January 11th
by Zacks Equity Research
HHS, WTKWY and ELF made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 11, 2023.
Is AppHarvest (APPH) Outperforming Other Business Services Stocks This Year?
by Zacks Equity Research
Here is how AppHarvest, Inc. (APPH) and Harte-Hanks (HHS) have performed compared to their sector so far this year.
Should Value Investors Buy Harte Hanks (HHS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.